These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Evaluation of two combination chemotherapies in previously untreated non Hodgkin's lymphoma. Somoza N, Pavlovsky S, Suárez A, Morgenfeld M, Besuschio SC, Bezares R, Quiroga Micheo E, Lein JM, De María H. Medicina (B Aires); 1981; 41 Suppl():35-43. PubMed ID: 7345350 [No Abstract] [Full Text] [Related]
11. [Critical analysis of therapeutic results in malignant non-Hodgkin lymphomas]. Gociu M, Butoianu E, Munteanu N, Coliţă D, Stoica I, Dosius L, Munţiu R, Guran M, Gheorghiţă E, Berceanu S. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):521-30. PubMed ID: 6113671 [No Abstract] [Full Text] [Related]
15. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model. Mohammad RM, Wall NR, Dutcher JA, Al-Katib AM. Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256 [Abstract] [Full Text] [Related]